Motif Neurotech’s Skull Implant: A New Frontier in Fighting Treatment-Resistant Depression

This FDA-approved human trial marks a pivotal shift in mental health tech by offering a less invasive, home-based solution for millions who don't respond to traditional antidepressants. Unlike Neuralink's focus on paralysis, Motif targets cognitive networks to restore daily function, potentially democratizing advanced neuro-stimulation therapy.